Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Mucopolysaccharidosis type II (MPSII; Hunter syndrome) is a lysosomal storage disorder caused by a deficiency in the enzyme iduronate 2-sulfatase (IDS). At present, the therapeutic approaches for MPSII are enzyme replacement therapy and bone marrow transplantation, although these therapies have some limitations. The availability of new AAV serotypes that display tissue-specific tropism and promote sustained expression of transgenes offers the possibility of AAV-mediated gene therapy for the systemic treatment of lysosomal diseases, including MPSII. We have characterized in detail the phenotype of IDS-deficient mice, a model of human MPSII. These mice display a progressive accumulation of glycosaminoglycans (GAGs) in many organs and excessive excretion of these compounds in their urine. Furthermore, they develop skeleton deformities, particularly of the craniofacial bones, and alopecia, they perform poorly in open-field tests and they have a severely compromised walking pattern. In addition, they present neuropathological defects. We have designed an efficient gene therapy approach for the treatment of these MPSII mice. AAV2/8TBG-IDS viral particles were administrated intravenously to adult MPSII mice. The plasma and tissue IDS activities were completely restored in all of the treated mice. This rescue of the enzymatic activity resulted in the full clearance of the accumulated GAGs in all of the tissues analyzed, the normalization of the GAG levels in the urine and the correction of the skeleton malformations. Overall, our findings suggest that this in vivo gene transfer approach has potential for the systemic treatment of patients with Hunter syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
Wang, L., Calcedo, R., Nichols, T. C., Bellinger, D. A., Dillow, A., Verma, I. M., & Wilson, J. M. (2005) · Blood · doi:10.1182/blood-2004-10-3867 · Cited by 173
Brooks, D. A., Kakavanos, R., & Hopwood, J. J. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.004 · Cited by 95 · cited 1×
“Repeated administration of the enzyme increases the likelihood of an immune response against the infused protein, and this can affect the efficacy of the treatment ( 6 ).”
Background
Cited by
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
A block of autophagy in lysosomal storage disorders
Settembre, C., Fraldi, A., Jahreiss, L., Spampanato, C., Venturi, C., Medina, D., de Pablo, R., Tacchetti, C., Rubinsztein, D. C., & Ballabio, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm289 · Cited by 506
Self-citationRecognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Muñoz, V., & Muenzer, J. (2008) · Pediatrics · doi:10.1542/peds.2007-1350 · Cited by 314
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254
“We chose to use NHP for these studies for the following reasons: (1) there is considerable experience with IS drugs28-30 and with AAV vector infusion31-33 in NHP, so the baseline toxicities for both types of agents are well-described in these animals; (2) IS drugs such as daclizumab (the humanized anti–IL-2 receptor a…”
MethodLaoharawee, K., DeKelver, R. C., Podetz-Pedersen, K. M., Rohde, M., Sproul, S., Nguyen, H.-O., Nguyen, T., St. Martin, S. J., Ou, L., Tom, S., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.002 · Cited by 125
Metadata
- Authors
- Cardone, M., Polito, V. A., Pepe, S., Mann, L., D'Azzo, A., Auricchio, A., Ballabio, A., & Cosma, M. P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-27
- Volume
- 15
- Issue
- 7
- Pages
- 1225-1236
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2149353660
- Cited by
- 99
- References
- 3
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery. https://app.cochat.ai/papers/10.1093/hmg/ddl038
- The paper
- Cardone, M., Polito, V. A., Pepe, S., Mann, L., D'Azzo, A., Auricchio, A., Ballabio, A., & Cosma, M. P. (2006). Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddl038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.